TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nec Oncoimmunity AS
Closing information (x1000 EUR)
| Closing information | 2023/03 | 2022/03 | 2021/03 |
| Turnover |
285
|
248
|
732 |
| Financial expenses |
212
|
85
|
93 |
| Earnings before taxes |
-3,213
|
-2,518
|
-2,127 |
| Total assets |
6,448
|
13,754
|
3,793 |
| Current assets |
5,765
|
12,767
|
3,768 |
| Current liabilities |
1,093
|
3,665
|
1,667 |
| Equity capital |
5,355
|
10,090
|
2,126 |
| - share capital |
31
|
30
|
28 |
| Employees (average) | 18 | 16 |
Financial ratios
| Fiscal year | 2023/03 | 2022/03 | 2021/03 |
| Solvency |
83.0%
|
73.4%
|
56.1% |
| Turnover per employee | 16 | 46 | |
| Profit as a percentage of turnover |
-1127.4%
|
-1015.3%
|
-290.6% |
| Return on assets (ROA) |
-46.5%
|
-17.7%
|
-53.6% |
| Current ratio |
527.4%
|
348.3%
|
226.0% |
| Return on equity (ROE) |
-60.0%
|
-25.0%
|
-100.0% |
| Change turnover |
74
|
-514
|
-833 |
| Change turnover % |
35%
|
-67%
|
-53% |
| Chg. No. of employees | 1 | ||
| Chg. No. of employees % | 7% |
Total value of public sale
| Fiscal year | 2023/03 | 2022/03 | 2021/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.